You are here

  • Home
  • Archive
  • Volume 65, Issue 4
  • An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab

Citation Tools

Article menu
Download PDFPDF
Concise report
An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sidiropoulos PI, Siakka P, Raptopoulou A, et al
An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab
Annals of the Rheumatic Diseases 2006;65:538-541.